USANA Board of Directors Appoints Dave Wentz and Kevin Guest as Co-Chief Executive Officers
05 8월 2015 - 5:17AM
Business Wire
USANA Health Sciences, Inc. (NYSE: USNA) today announced that
the Board of Directors has appointed Dave Wentz and Kevin Guest as
Co-Chief Executive Officers of the Company, effective immediately.
Mr. Wentz will oversee USANA’s global operations, while Mr. Guest
will lead USANA’s worldwide field development and sales efforts.
Both Mr. Guest and Mr. Wentz will report directly to the Board of
Directors.
Dr. Myron Wentz, USANA’s founder and Chairman of the Board,
commented, “Kevin has been with USANA for over 20 years, most
recently as President, and has played a key role in leading USANA
to new heights in sales and financial performance. Dave has also
been with USANA for over 20 years and has served in executive
positions for much of that time, most recently as Chief Executive
Officer. As USANA approaches the $1 billion revenue milestone, the
Board is preparing for the next chapter of growth. With USANA’s
expanding global presence, and the demands on the chief executive
position, the Board determined that a division of responsibilities
within the CEO role would maximize USANA’s potential.”
Dave Wentz commented, “Kevin and I have worked as a team both
formally and informally for more than 20 years, and he has
demonstrated his leadership skills as President of our company. It
is exciting to be able to recognize Kevin for his contributions and
have him join me as Co-CEO. I look forward to sharing with him the
growing CEO responsibilities as USANA capitalizes on its many
growth and expansion opportunities.”
Kevin Guest commented, “I am honored by the recognition from the
Board of Directors and Dave. Dave and I have worked side by side to
achieve many goals over the years, and I look forward to working
with Dave and the rest of our team as we take USANA to the next
stage of growth.”
USANA also reported today that Paul Jones, Chief Financial
Officer, has been appointed Chief Leadership Development Officer,
where he will be responsible for the key role of overseeing USANA’s
global executive development and succession planning program. Mr.
Jones will continue his CFO responsibilities while the Company
initiates a search for a new Chief Financial Officer.
About USANA
USANA develops and manufactures high-quality nutritional
supplements, healthy foods and personal care products that are sold
directly to Associates and Preferred Customers throughout the
United States, Canada, Australia, New Zealand, Hong Kong, China,
Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the
Philippines, the Netherlands, the United Kingdom, Thailand, France,
Belgium and Colombia. More information on USANA can be found at
http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act. Our actual results could differ
materially from those projected in these forward-looking
statements, which involve a number of risks and uncertainties,
including global economic conditions generally, reliance upon our
network of independent Associates, the governmental regulation of
our products, manufacturing and marketing risks, adverse publicity
risks, and risks associated with our international expansion. The
contents of this release should be considered in conjunction with
the risk factors, warnings, and cautionary statements that are
contained in our most recent filings with the Securities and
Exchange Commission.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150804006816/en/
USANA Health Sciences, Inc.Investors contact:Patrique Richards,
801-954-7961Investor
Relationsinvestor.relations@us.usana.comorMedia contact:Dan Macuga,
801-954-7280Public Relations
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024